Genfit SA GNFTF:OTCPK

*Data is delayed | Exchange | USD
Last | 04/15/24 EDT
2.95UNCH (UNCH)
52 week range
2.95 - 4.39
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.95
  • 52 Week High4.39
  • 52 Week High Date05/09/23
  • 52 Week Low2.95
  • 52 Week Low Date04/15/24

Key Stats

  • Market Cap170.74M
  • Shares Out49.83M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-14.49

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.95
  • 52 Week High4.39
  • 52 Week High Date05/09/23
  • 52 Week Low2.95
  • 52 Week Low Date04/15/24
  • Market Cap170.74M
  • Shares Out49.83M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-14.49

RATIOS/PROFITABILITY

  • EPS (TTM)-0.64
  • P/E (TTM)-4.60
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date09/19/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genfit SA

 

Profile

MORE
Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory...
Jean-Francois Mouney
Chairman of the Board
Xavier Guille Des Buttes
Independent Vice Chairman of the Board
Pascal Prigent
Chief Executive Officer
Pascal Caisey
Chief Operating Officer
Thomas Baetz
Chief Financial Officer
Meriam Kabbaj Ph.D.
Chief Technology Officer
Emilie Desodt
Executive Vice President of Human Resources
Address
Parc Eurasante 885 avenue Eugene Avinee
Loos
59120
France